TSI and Its Relationship With Graves' Disease Relapse

CompletedOBSERVATIONAL

Enrollment

352

Participants

Timeline

Start Date

January 2, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions

Graves DiseaseImmunoglobulinAnti-Thyroid Antibodies Disorder

Interventions

DIAGNOSTIC_TEST

TSI

TSI was measured several times during the course of treatment when planning to stop medication (at the discretion of the attending physician).

Trial Locations (1)

Hoa Hao Clinic, Ho Chi Minh City

All Listed Sponsors

lead

University of Medicine and Pharmacy at Ho Chi Minh City

OTHER

NCT05713097 - TSI and Its Relationship With Graves' Disease Relapse | Biotech Hunter | Biotech Hunter